Advances in Sarcoma Treatment Webinar Series
Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management. This webinar series, Advances in Sarcoma Treatment, will bring experts in oncology, radiology, radiation therapy and radiation oncology to discuss cutting-edge advancements in sarcoma diagnosis and treatment. The series is divided into three one-hour webinars, each focusing on a key aspect of sarcoma management: advanced imaging, complex sarcoma cases and novel radiation techniques.
This webinar series will serve as a valuable platform for sarcoma specialists to share knowledge, discuss challenging cases, and explore innovative approaches to treatment. The insights from these sessions will contribute to improving patient care and fostering collaborative efforts in sarcoma research and management.
TOPICS COVERED
- Imaging of Soft Tissue Sarcoma: Pearls and Pitfalls
- Data-informed Approaches for the Management of Angiosarcoma in the Modern Era
- Special Radiation Techniques in Sarcoma Management
Please see the Program tab for the session descriptions and presenters.
This activity is available from June 4, 2025 through 11:59 pm Eastern time on July 5, 2027.
Target Audience
This activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, nurses, diagnostic radiologists, physicists, dosimetrists, radiation biologists, radiation therapists, pathologists, residents and allied healthcare professionals interested in sarcoma management.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand the latest imaging modalities and AI applications in sarcoma diagnosis and treatment planning.
- Gain insight into the complexities of managing angiosarcoma and chordoma with emerging therapies.
- Learn about cutting-edge radiation therapy techniques that enhance treatment efficacy and reduce toxicity.
Imaging of Soft Tissue Sarcoma: Pearls and Pitfalls
Wednesday, July 2 - 1:00 pm - 2:00 pm ET
- Stephen M. Broski, MD
- Moderator: Meng Welliver, MD, PhD
The purpose of this webinar is to review characteristic multimodality imaging features of soft tissue sarcoma (STS), discuss MRI imaging protocols, identify imaging features of STS that may allow for a specific diagnosis or narrow the differential diagnosis prior to biopsy, cover potential imaging pitfalls of STS, and discuss specific issues that may impact radiation therapy.
Data-informed Approaches for the Management of Angiosarcoma in the Modern Era
Monday, July 14 - 1:30 pm - 2:30 pm ET
- Parul Barry, MD
- Moderator: Meng Welliver, MD, PhD
Angiosarcoma is both aggressive and rare, and treatment approaches are varied. While those who receive multi-modal care routinely experience the best outcomes, often radiation oncology is not engaged in such decisions. This webinar will provide learners with guidance on how to best approach such difficult cases and advocate for when radiation could help patients afflicted with this deadly disease.
Special Radiation Techniques in Sarcoma Management
Friday, July 18 - 12:30 pm - 1:30 pm ET
- Anusha Kalbasi, MD
- Moderator: Meng Welliver, MD, PhD
There are many ongoing advances in the context of radiation therapy delivery for patients with primary soft tissue sarcoma of the extremity/trunk with emerging practice-changing clinical research and new treatment options, some of which are not yet standard of care. This presentation discusses new approaches in the management of sarcoma using radiation therapy, including novel fractionation schedules, novel dose strategies and novel combinations with systemic therapy.
- Meng Welliver, MD, PhD, is employed by Mayo Clinic Alix School of Medicine.
- Stephen M. Broski, MD, is employed by Mayo Clinic Rochester.
- Parul Barry, MD, is employed by UPMC Radiation Oncology. Dr. Barry receives travel expenses and grant research funding from ASTRO and ACRO. Dr. Barry receives grant/research funding from the Beckwith Foundation, Silverlon and Philanthropy. Dr. Barry receives honoraria from Elsevier Pathways and the Pittsburgh Foundation. Dr. Barry serves in an uncompensated role with ARS and ABS Guidelines. Dr. Barry is Chair of Education on the HEDI Council of ASTRO.; Director of Research and Scientific Program with the Women in Medicine Summit; Senior Associate Editor for the Journal on Rare Tumors; and is a Senior Advisory Committee Member for the Society of Women in Radiation Oncology (SWRO).
- Anusha Kalbasi, MD, is employed by Stanford University. Dr. Kalbasi owns stock in Certis Oncology; receives compensation/payment from T Cure Therapeutics; and receives grant/research funding from Highlight Therapeutics.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 Certificate of AttendanceThis activity was designated for 3.00 AMA PRA Category 1 Credit™.
Price
Course fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Member: $199
Member-in-training: $99
Member Student/Grad Student/PGY: $99
Member Postdoctoral Fellow: $99
Nonmember: $299
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until July 5, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.